These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 20108221)

  • 41. Prediction of pre-eclampsia and its subtypes in high-risk cohort: hyperglycosylated human chorionic gonadotropin in multivariate models.
    Murtoniemi K; Villa PM; Matomäki J; Keikkala E; Vuorela P; Hämäläinen E; Kajantie E; Pesonen AK; Räikkönen K; Taipale P; Stenman UH; Laivuori H
    BMC Pregnancy Childbirth; 2018 Jul; 18(1):279. PubMed ID: 29970026
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Competing risk model in screening for preeclampsia by mean arterial pressure and uterine artery pulsatility index at 30-33 weeks' gestation.
    Tayyar A; Garcia-Tizon Larroca S; Poon LC; Wright D; Nicolaides KH
    Fetal Diagn Ther; 2014; 36(1):18-27. PubMed ID: 24970282
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Fetal fraction of cell free DNA in screening for hypertensive disorders at 11-13 weeks.
    Sapantzoglou I; Gallardo Arozena M; Dragoi V; Akolekar R; Nicolaides KH; Syngelaki A
    J Matern Fetal Neonatal Med; 2022 Dec; 35(25):5363-5368. PubMed ID: 33517808
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Screening for preeclampsia using first-trimester serum markers and uterine artery Doppler in nulliparous women.
    Audibert F; Boucoiran I; An N; Aleksandrov N; Delvin E; Bujold E; Rey E
    Am J Obstet Gynecol; 2010 Oct; 203(4):383.e1-8. PubMed ID: 20691410
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Competing risks model in early screening for preeclampsia by biophysical and biochemical markers.
    Akolekar R; Syngelaki A; Poon L; Wright D; Nicolaides KH
    Fetal Diagn Ther; 2013; 33(1):8-15. PubMed ID: 22906914
    [TBL] [Abstract][Full Text] [Related]  

  • 46. First-trimester screening for early and late preeclampsia using maternal characteristics, biomarkers, and estimated placental volume.
    Sonek J; Krantz D; Carmichael J; Downing C; Jessup K; Haidar Z; Ho S; Hallahan T; Kliman HJ; McKenna D
    Am J Obstet Gynecol; 2018 Jan; 218(1):126.e1-126.e13. PubMed ID: 29097177
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Combined screening for early and late pre-eclampsia and intrauterine growth restriction by maternal history, uterine artery Doppler, mean arterial pressure and biochemical markers.
    Litwińska E; Litwińska M; Oszukowski P; Szaflik K; Kaczmarek P
    Adv Clin Exp Med; 2017; 26(3):439-448. PubMed ID: 28791818
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Performance of a first-trimester screening of preeclampsia in a routine care low-risk setting.
    Scazzocchio E; Figueras F; Crispi F; Meler E; Masoller N; Mula R; Gratacos E
    Am J Obstet Gynecol; 2013 Mar; 208(3):203.e1-203.e10. PubMed ID: 23246313
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Maternal plasma inhibin A at 11-13 weeks of gestation in hypertensive disorders of pregnancy.
    Akolekar R; Minekawa R; Veduta A; Romero XC; Nicolaides KH
    Prenat Diagn; 2009 Aug; 29(8):753-60. PubMed ID: 19412915
    [TBL] [Abstract][Full Text] [Related]  

  • 50. First-trimester uterine artery Doppler and serum pregnancy-associated plasma protein-a in preeclampsia and chromosomal defects.
    Staboulidou I; Galindo A; Maiz N; Karagiannis G; Nicolaides KH
    Fetal Diagn Ther; 2009; 25(3):336-9. PubMed ID: 19776597
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Repeat measurements of uterine artery pulsatility index, mean arterial pressure and serum placental growth factor at 12, 22 and 32 weeks in prediction of pre-eclampsia.
    Andrietti S; Carlucci S; Wright A; Wright D; Nicolaides KH
    Ultrasound Obstet Gynecol; 2017 Aug; 50(2):221-227. PubMed ID: 28078815
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Uterine artery Doppler at 11 + 0 to 13 + 6 weeks and 21 + 0 to 24 + 6 weeks in the prediction of pre-eclampsia.
    Plasencia W; Maiz N; Poon L; Yu C; Nicolaides KH
    Ultrasound Obstet Gynecol; 2008 Aug; 32(2):138-46. PubMed ID: 18634131
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prediction of pre-eclampsia by a combination of maternal history, uterine artery Doppler and mean arterial pressure.
    Onwudiwe N; Yu CK; Poon LC; Spiliopoulos I; Nicolaides KH
    Ultrasound Obstet Gynecol; 2008 Dec; 32(7):877-83. PubMed ID: 18991324
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Impact of replacing or adding pregnancy-associated plasma protein-A at 11-13 weeks on screening for preterm pre-eclampsia.
    Wah YMI; Sahota DS; Chaemsaithong P; Wong L; Kwan AHW; Ting YH; Law KM; Leung TY; Poon LC
    Ultrasound Obstet Gynecol; 2022 Aug; 60(2):200-206. PubMed ID: 35468236
    [TBL] [Abstract][Full Text] [Related]  

  • 55. First-trimester screening for early and late small-for-gestational-age neonates using maternal serum biochemistry, blood pressure and uterine artery Doppler.
    Crovetto F; Crispi F; Scazzocchio E; Mercade I; Meler E; Figueras F; Gratacos E
    Ultrasound Obstet Gynecol; 2014 Jan; 43(1):34-40. PubMed ID: 23754253
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prediction of preeclampsia in primigravida in late first trimester using serum placental growth factor alone and by combination model.
    Agarwal R; Chaudhary S; Kar R; Radhakrishnan G; Tandon A
    J Obstet Gynaecol; 2017 Oct; 37(7):877-882. PubMed ID: 28569565
    [TBL] [Abstract][Full Text] [Related]  

  • 57. First-trimester markers for the prediction of pre-eclampsia in women with a-priori high risk.
    Khalil A; Cowans NJ; Spencer K; Goichman S; Meiri H; Harrington K
    Ultrasound Obstet Gynecol; 2010 Jun; 35(6):671-9. PubMed ID: 20069559
    [TBL] [Abstract][Full Text] [Related]  

  • 58. MoM cutoffs for variables, an important tool for multivariate analysis and accurate interpretation of preeclampsia risk in high-risk pregnancy at 11-13
    Verma J; Thomas DC; Jhingan G; Puri RD; Verma IC
    Hypertens Pregnancy; 2016 Nov; 35(4):548-558. PubMed ID: 27599037
    [TBL] [Abstract][Full Text] [Related]  

  • 59. First-trimester screening for preeclampsia: impact of maternal parity on modeling and screening effectiveness.
    Moon M; Odibo A
    J Matern Fetal Neonatal Med; 2015; 28(17):2028-33. PubMed ID: 25330843
    [TBL] [Abstract][Full Text] [Related]  

  • 60. First-trimester 3-dimensional power Doppler placental vascularization indices from the whole placenta versus the placental bed to predict preeclampsia: does pregnancy-associated plasma protein a or uterine artery Doppler sonography help?
    Hannaford KE; Tuuli M; Goetzinger KR; Odibo L; Cahill AG; Macones G; Odibo AO
    J Ultrasound Med; 2015 Jun; 34(6):965-70. PubMed ID: 26014314
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.